LYCOS RETRIEVER
Medication: Medications
built 199 days ago
Medication is an essential part of successful treatment for bipolar disorder, and valproic acid is among the most well studied medications approved to treat mania. With the proper dosage, valproic acid can reduce manic symptoms, shorten hospitalizations, help prevent future manic episodes, and make it possible for an individual to live productively in the community.
Source:
Medication can be useful in preventing some seizure s From Chicago Sun-Times on 09/08/1991 and prevent seizures. It is extremelytake their medication exactly asSkipping the medication allows thelevel of the medication to drop and seizures most likelythe type of seizure is correct and the […]
Source:
The first medication specifically approved for use in the treatment of OCD was the tricyclic antidepressant clomipramine (Anafranil). The SSRIs, fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft) have now been approved for use with OCD. Paroxetine has ... been approved for social anxiety disorder (social phobia), GAD, and panic disorder; and sertraline is approved for panic disorder and PTSD. Venlafaxine (Effexor) has been approved for GAD.
Source:
-- The end-user warning message at the cabinet that the issue amount exceeds the medication order dose amount can be disabled. -- Messages and business rules have been modified to allow the user to clearly identify the last time this medication or medication order was issued at the cabinet. If medication has been issued, the date and time will be displayed; if not, "Item has not been issued" will be displayed. When system-wide last issue is enabled and data are unable to be obtained for both medications and medication orders, users will be notified with a last issue message, displaying "Information not available." -- At the cabinet, the user now has the ability to view the current temperature within the FlexLock refrigerator at the logon screen, providing on-demand, real-time information to the nurse and other individuals. This supplements the FlexLock with TempCheck(TM) feature that is currently available.
Source:
The decision to use a psychotropic medication should be made only after a careful discussion between the woman, her partner, and her doctor about the risks and benefits to her and the baby. If, after discussion, they agree it best to continue medication, the lowest effective dosage should be used, or the medication can be changed. For a woman with an anxiety disorder, a change from a benzodiazepine to an antidepressant might be considered. Cognitive-behavioral therapy may be beneficial in helping an anxious or depressed person to lower medication requirements. For women with severe mood disorders, a course of electroconvulsive therapy (ECT) is sometimes recommended during pregnancy as a means of minimizing exposure to riskier treatments.
Source:
In initial studies, between 5% and 15% of people who used this medication reported a gradual change in eye color, due to an increased amount of brown pigment in the iris of the treated eye. The change in eye color occurs slowly and may not be noticeable for several months to years. Other side effects can include stinging, blurred vision, eye redness, itching, and burning. These medications are new to the market, and long term follow up of people who use them is not yet available.
Source: